These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


316 related items for PubMed ID: 18723569

  • 21. Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique.
    Ronco C, Brendolan A, Crepaldi C, Rodighiero M, Scabardi M.
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S53-61. PubMed ID: 11792763
    [Abstract] [Full Text] [Related]

  • 22. Daptomycin clearance during modeled continuous renal replacement therapy.
    Churchwell MD, Pasko DA, Mueller BA.
    Blood Purif; 2006 Jan; 24(5-6):548-54. PubMed ID: 17124423
    [Abstract] [Full Text] [Related]

  • 23. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Eloot S, de Vos JY, de Vos F, Hombrouckx R, Verdonck P.
    Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
    [Abstract] [Full Text] [Related]

  • 24. Interaction between valproic acid and carbamazepine: an in vitro study of protein binding.
    Mattson GF, Mattson RH, Cramer JA.
    Ther Drug Monit; 1982 Oct; 4(2):181-4. PubMed ID: 6808714
    [Abstract] [Full Text] [Related]

  • 25. Extracorporeal removal of toxic valproic acid levels in children.
    Dharnidharka VR, Fennell RS, Richard GA.
    Pediatr Nephrol; 2002 May; 17(5):312-5. PubMed ID: 12042885
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: in vitro studies.
    Mariano F, Fonsato V, Lanfranco G, Pohlmeier R, Ronco C, Triolo G, Camussi G, Tetta C, Passlick-Deetjen J.
    Nephrol Dial Transplant; 2005 Jun; 20(6):1116-26. PubMed ID: 15814541
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Successful treatment of severe carbamazepine toxicity with 5% albumin-enhanced continuous venovenous hemodialysis.
    Narayan R, Rizzo M, Cole M.
    J Artif Organs; 2014 Jun; 17(2):206-9. PubMed ID: 24449266
    [Abstract] [Full Text] [Related]

  • 31. Slow continuous ultrafiltration with bound solute dialysis.
    Patzer JF, Safta SA, Miller RH.
    ASAIO J; 2006 Jun; 52(1):47-58. PubMed ID: 16436890
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M, Huitema AD, Boogerd W, van der Sande JJ, Schellens JH, Beijnen JH.
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Enhanced Indoxyl Sulfate Dialyzer Clearance with the Use of Binding Competitors.
    Tao X, Thijssen S, Levin N, Kotanko P, Handelman G.
    Blood Purif; 2015 Aug; 39(4):323-30. PubMed ID: 25998324
    [Abstract] [Full Text] [Related]

  • 36. Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial.
    Luo FJ, Patel KP, Marquez IO, Plummer NS, Hostetter TH, Meyer TW.
    Am J Kidney Dis; 2009 Jun; 53(6):1042-9. PubMed ID: 19394728
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Flow distribution analysis by helical scanning in polysulfone hemodialyzers: effects of fiber structure and design on flow patterns and solute clearances.
    Ronco C, Levin N, Brendolan A, Nalesso F, Cruz D, Ocampo C, Kuang D, Bonello M, De Cal M, Corradi V, Ricci Z.
    Hemodial Int; 2006 Oct; 10(4):380-8. PubMed ID: 17014516
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
    Meijers B, Toussaint ND, Meyer T, Bammens B, Verbeke K, Vanrenterghem Y, Kerr PG, Evenepoel P.
    Am J Nephrol; 2011 Oct; 34(3):226-32. PubMed ID: 21791919
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.